Mesenchymal Stem Cell-Derived Secretome and Extracellular Vesicles Attenuate Progression of Inflammation and Cartilage Destruction in Inflammatory Arthritis - Oksana Kehoe (Keele University)
12:00pm - 1:00pm /
Monday 19th February 2018
/ Venue: Lecture Theatre 1 Life Sciences Building
- Dada Pisconti
- Suitable for: Staff/students with an interest in Genomes, Systems and Therapeutic Targeting
- Admission: Free
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
Rheumatoid arthritis (RA) is a debilitating and painful disorder affecting more than 690,000 people in the UK, with 12,000 new cases diagnosed annually. Novel biological therapies have revolutionised the management of RA. However, up to 30% of RA patients fail to respond to currently available biological therapeutics and 50% of those prescribed the treatment discontinue use after 2 years. It is therefore vital to develop a new, effective therapy for RA. Mesenchymal stem cells (MSCs) possess anti-inflammatory and immunosuppressive properties that may be exploited therapeutically. We have previously demonstrated that intra-articular) injection of MSCs reduces inflammation and cartilage damage in antigen-induced arthritis (AIA). In my presentation, I will discuss data from our lab for the application of MSCs-derived secretome and extracellular vesicles in inflammatory arthritis.